Cargando…
Intranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB/c mice against infection
BACKGROUND: Previously, we demonstrated that unlike subcutaneous or intramuscular vaccination, intranasal vaccination of BALB/c mice with whole Leishmania amazonensis antigens leads to protection against cutaneous leishmaniasis. Here, the role of parasite serine proteases in the protective immunity...
Autores principales: | de Matos Guedes, Herbert Leonel, da Silva Costa, Beatriz Lilian, Chaves, Suzana Passos, de Oliveira Gomes, Daniel Cláudio, Nosanchuk, Joshua Daniel, De Simone, Salvatore Giovanni, Rossi-Bergmann, Bartira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261548/ https://www.ncbi.nlm.nih.gov/pubmed/25239157 http://dx.doi.org/10.1186/1756-3305-7-448 |
Ejemplares similares
-
Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice
por: Pratti, Juliana Elena Silveira, et al.
Publicado: (2016) -
Simvastatin Resistance of Leishmania amazonensis Induces Sterol Remodeling and Cross-Resistance to Sterol Pathway and Serine Protease Inhibitors
por: Fujii, Thais Tenorio Soares, et al.
Publicado: (2022) -
The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy
por: Pratti, Juliana Elena Silveira, et al.
Publicado: (2019) -
Effects of a Serine Protease Inhibitor N-p-Tosyl-L-phenylalanine Chloromethyl Ketone (TPCK) on Leishmania amazonensis and Leishmania infantum
por: Machado, Patrícia de A., et al.
Publicado: (2022) -
Characterization of Sv129 Mice as a Susceptible Model to Leishmania amazonensis
por: dos-Santos, Júlio Souza, et al.
Publicado: (2019)